Advertisement
Ascendis Pharma Says FDA Accepts Resubmitted NDA For TransCon PTH In Adults With Hypoparathyroidism
(RTTNews) - Ascendis Pharma A/S (ASND) announced Monday that the U.S. Food & Drug Administration (FDA) has accepted for review the Company's resubmitted New Drug Application (NDA) for TransCon PTH (palopegteriparatide) for the treatment of adult patients with hypoparathyroidism.
The agency considered the resubmission a complete, class 2 response and set a Prescription Drug User Fee Act (PDUFA) goal date of May 14, 2024.
In the United States, TransCon PTH (palopegteriparatide) is an investigational prodrug of parathyroid hormone (PTH [1-34]) for adult patients with hypoparathyroidism.
read more
Ascendis Pharma Says UK Approves YORVIPATH For Treatment Of Adults With Chronic Hypoparathyroidism
Danish pharmaceutical company Ascendis Pharma A/S (ASND) announced that the United Kingdom's Medicines & Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for YORVIPATH (palopegteriparatide; developed as TransCon PTH) in Great Britain as a parathyroid hormone (PTH) replacement therapy indicated for the treatment of adults with chronic hypoparathyroidism
RTTNews
|
380 dias atrás
U.S. Dollar Declines On Trade Deal Optimism
The U.S. dollar weakened against its major counterparts in the New York session on Friday as investors looked ahead to discussions between the U.S. and China scheduled for this weekend.
RTTNews
|
1h 36min atrás
Swiss Market Ends On Positive Note
The Swiss market closed higher on Friday as easing concerns about trade tensions following the announcement of a trade deal between the U.S. and U.K., and upcoming talks between U.S. and China helped keep the mood positive.
RTTNews
|
3h 41min atrás
European Stocks Close On Firm Note On Trade Deal Optimism, Earnings
European stocks closed higher on Friday amid optimism about the U.S. and China agreeing on a trade deal this weekend, close on the heels of U.S. President Donald Trump unveiling the framework of a trade agreement with the U.K. on Thursday.
RTTNews
|
4h 5min atrás
TSX Modestly Higher On Positive Jobs Data, Earnings Updates
The Canadian market is modestly higher around noon on Friday, riding on gains in communications, energy and materials sectors.
Optimism about the U.S. and China agreeing on a trade deal this weekend, close on the heels of U.S. President Donald Trump unveiling the framework of a trade agreemen
RTTNews
|
5h 10min atrás
Bay Street Headed For Positive Start
Firm commodity prices and steady global stocks amid optimism about trade deals point to a positive start for the Canadian market on Friday. Canadian jobs data for the month of April, and corporate earnings updates are also set to make an impact.
RTTNews
|
8h 28min atrás
FTSE Up Nearly 0.5% On Easing Tariff Concerns
U.K. stocks are up on Friday, supported by some strong earnings updates, and continued optimism about trade deals.
U.S. President Donald Trump said on Thursday that the meetings with China on trade and economic issues could be "very substantive" and lead to tariff reductions.
RTTNews
|
10h 10min atrás
CAC 40 Up 0.75% On Easing Trade Tensions
French stocks are exhibiting strength on Friday, buoyed by news about the U.S. and U.K. agreeing on a trade deal, and the upcoming U.S. - China trade talks this weekend.
RTTNews
|
10h 45min atrás
